These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 18676097)
1. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097 [TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725 [TBL] [Abstract][Full Text] [Related]
3. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer. Chen PV; Osborne R; Ahn E; Avitia S; Juillard G Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515 [TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Rosenbluth BD; Serrano V; Happersett L; Shaha AR; Tuttle RM; Narayana A; Wolden SL; Rosenzweig KE; Chong LM; Lee NY Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1419-26. PubMed ID: 16154712 [TBL] [Abstract][Full Text] [Related]
6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0. Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer. Kim JH; Kim MS; Yoo SY; Lim SM; Lee GH; Yi KH Otolaryngol Head Neck Surg; 2010 Mar; 142(3):338-43. PubMed ID: 20172377 [TBL] [Abstract][Full Text] [Related]
11. External beam radiation therapy for thyroid cancer. Brierley JD; Tsang RW Endocrinol Metab Clin North Am; 2008 Jun; 37(2):497-509, xi. PubMed ID: 18502339 [TBL] [Abstract][Full Text] [Related]
12. Response to "Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience" (Int J Radiat Oncol Biol Phys 2009;73:795-801). Mehrotra PK; Mishra A Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):314; author reply 314. PubMed ID: 20005461 [No Abstract] [Full Text] [Related]
13. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS). Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Brierley J; Tsang R; Panzarella T; Bana N Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234 [TBL] [Abstract][Full Text] [Related]
15. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Chow SM; Yau S; Kwan CK; Poon PC; Law SC Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Glanzmann C; Lütolf UM Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660 [TBL] [Abstract][Full Text] [Related]
17. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172 [TBL] [Abstract][Full Text] [Related]
18. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605 [TBL] [Abstract][Full Text] [Related]
19. [The role of external radiotherapy in the treatment of medullary carcinoma of the thyroid]. Costa MA; Sousa O; Azevedo I; Castro C; Fernandes T; Vieira E Acta Med Port; 1998 Jun; 11(6):539-42. PubMed ID: 9773532 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter. Zhang Q; Fu S; Liu T; Peng L; Huang G; Lu JJ Urol Oncol; 2009; 27(1):14-20. PubMed ID: 18367127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]